As part of its patient support program AstraZeneca’s respiratory franchise will utilize WellDoc’s web- and mobile-based asthma solution, including virtual messenger, air quality and pollen count alerts as well as online patient support tools, allowing patients to manage their condition, consistent with the treatment plan of the patient’s physician, throughout their day and in real time.
WellDoc’s asthma application is said to include many features that benefit patients, including reminders, alerts, medication data capture and pollen and air quality data.
Ryan Sysko, CEO of WellDoc, said: “We’re pleased to announce our collaboration with AstraZeneca. Our partnership demonstrates WellDoc’s ability to expand beyond diabetes into other chronic conditions, but our focus remains the same -the improvement of healthcare outcomes and reduction of healthcare costs.”